Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Prostate Cancer × Gefitinib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Urinary Bladder Neoplasms 4 Carcinoma, Renal Cell 3 Kidney Neoplasms 2 Urethral Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-Metastatic Prostate Cancer 1 Locally Advanced Prostate Cancer 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

tislelizumab 1 pamiparib 1 TNFeraseBiologic 1 Injections 1 Gefitinib 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00319787 2011-01-25

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

AstraZeneca

Phase 2 Completed

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡